Ep. 171 - 2Q Markets Preview, Abortion Drug Rulings, Gilead Oncology
BioCentury This Week
00:00
The History of Gilead's Oncology Franchise
Gilead has done at least 12 deals over the last just a couple years where they've outlaid more than 40 billion to help build out this pipeline so it's a big investment. Kendall Square Orchestra provides the music for biocentric this week. Steve is speaking with Paul Stuffles head of Galapagos long time top exec at j and j tune in wherever you get your podcasts on our website or on our youtube channel all of biocentric podcasts are available on Spotify, Stitcher, Apple and Google.
Transcript
Play full episode
